Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new resource aimed to support psychiatrists dealing with the death of a patient by suicide is now available from the Centre for Suicide Research at the University of Oxford.

Director of the Centre for Suicide Research, University of Oxford, and Consultant Psychiatrist, Oxford Health NHS Foundation Trust, Professor Keith Hawton, said,

"The sad loss of patients to suicide can understandably have severe emotional and psychological effects on staff. A group of senior clinicians (psychiatrists, nurses and clinical psychologists), most of whom work in Oxford Health NHS Foundation Trust, formed a working party associated with the Centre for Suicide Research to investigate the impact on clinical staff of loss of patients to suicide. We have produced this new resource for psychiatrists who experience the death of a patient by suicide. The resource is partly based on findings of a survey of doctors about their experiences, which was carried out because of concerns about the considerable impacts loss of patients to suicide can have on psychiatrists.  We are in the process of also developing a resource for other mental health staff, again based on findings of a survey of experiences."

If a patient dies by suicide: A Resource for Psychiatrists, has been produced to support psychiatrists at all stages of their career, from trainees to experienced consultants. Its purpose is to provide information about a difficult topic that psychiatrists often avoid discussing, to reduce a sense of isolation, and to recommend helpful resources for those psychiatrists who have this experience.

The guide was developed following a survey of psychiatrists who had experienced the death of a patient by suicide (Gibbons et al. 2019), from a review of the limited research literature in this area and from personal experiences. 

 

We hope that this booklet will prove helpful for psychiatrists in the aftermath of patient suicide and for those who haven’t faced such a loss, including trainees, to help them cope should this happen in future. - Professor Keith Hawton.

 

 

 

 

 

 

 

 

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Just Over Half of British Indians Would Get COVID Vaccine

COVID-19 Mental Health

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

Mental Health Schizophrenia

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental Mental Health Worse Since New National Restrictions

COVID-19 Child and adolescent Early intervention Mental Health Psychological therapy

Parental stress, depression, and anxiety have again increased since new national restrictions have been introduced according to the latest report from the Oxford University led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study based on data from over 6000 UK parents.

Potential New Target to Prevent or Delay Dementia

Alzheimer's disease Dementia Mental Health Old-age psychiatry

New study shows targeting arterial stiffening earlier in a person’s lifespan could provide cognitive benefits in older age and may help to delay the onset of dementia.

SSRI Treatment in Young People with Depression and Anxiety

Anxiety Depression Mental Health

Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.

Collaborating with Youth is Key to Studying Mental Health Management

Anxiety Depression Mental Health

The Global Mental Health Databank, a feasibility study, hopes to enable youth from the United Kingdom, South Africa, and India to work directly with mental health researchers to better understand how young people can manage their own mental health.